10-Q 1 j0476_10q.htm 10-Q

 

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

 

FORM 10-Q

 

(Mark One)

 

 

 

 

 

ý

 

Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the quarterly period ended March 28, 2003 or

 

o

 

Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the period from            to           /

 

Commission file number: 000-30575

 

AVOCENT CORPORATION

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

 

91-2032368

(State or Other Jurisdiction of Incorporation or Organization)

 

(I.R.S. Employer Identification Number)

 

 

 

4991 Corporate Drive
Huntsville, Alabama

 

35805

(Address of Principal Executive Offices)

 

(Zip Code)

 

 

 

256-430-4000

(Registrant’s Telephone Number, Including Area Code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

 

ý Yes  o No

 

                Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Securities Exchange Act of 1934, as amended).

 

ý Yes  o No

 

As of May 6, 2003, the number of outstanding shares of the Registrant’s Common Stock was 45,877,343

 

 



 

AVOCENT CORPORATION

FORM 10-Q

March 28, 2003

 

INDEX

 

Part I

Financial Information

 

 

 

 

Item 1.

Financial Statements

 

 

 

 

 

Condensed Consolidated Statements of Operations (unaudited) for the Three Months Ended March 28, 2003 and March 29, 2002

 

 

Condensed Consolidated Balance Sheets at March 28, 2003 (unaudited) and December 31, 2002 (audited)

 

 

Condensed Consolidated Statements of Cash Flows (unaudited) for the Three Months Ended March 28, 2003 and March 29, 2002

 

 

Notes to Condensed Consolidated Financial Statements (unaudited)

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risks

 

 

 

 

Item 4.

Controls and Procedures

 

 

 

Part II

Other Information

 

 

 

 

Item 1.

Legal Proceedings

 

 

 

 

Item 6.

Exhibits and Reports on Form 8-K.

 

 

 

Signatures

Sarbanes-Oxley Act Section 302(a) Certifications

 

2



 

PART I —FINANCIAL INFORMATION

 

Item 1.  Financial Statements

 

AVOCENT CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

 

 

 

For the three months ended

 

 

 

March 28,
2003

 

March 29,
2002

 

 

 

(unaudited)

 

(unaudited)

 

Net sales

 

$

71,162

 

$

62,103

 

Cost of sales

 

31,565

 

31,840

 

Gross profit

 

39,597

 

30,263

 

 

 

 

 

 

 

Research and development expenses

 

6,812

 

6,437

 

Selling, general and administrative expenses

 

16,659

 

19,923

 

Amortization of intangible assets

 

6,156

 

5,297

 

Total operating expenses

 

29,627

 

31,657

 

 

 

 

 

 

 

Income (loss) from operations

 

9,970

 

(1,394

)

 

 

 

 

 

 

Net investment income

 

1,226

 

1,386

 

Net realized investment losses

 

(87

)

(75

)

Other income (expense), net

 

(305

)

53

 

 

 

 

 

 

 

Income (loss) before provision for (benefit from) income taxes

 

10,804

 

(30

)

Provision for (benefit from) income taxes

 

2,637

 

(333

)

 

 

 

 

 

 

Net income

 

$

8,167

 

$

303

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

Basic

 

$

0.18

 

$

0.01

 

 

 

 

 

 

 

Diluted

 

$

0.17

 

$

0.01

 

 

 

 

 

 

 

Weighted average shares used in computing earnings per share:

 

 

 

 

 

Basic

 

45,413

 

44,828

 

 

 

 

 

 

 

Diluted

 

46,691

 

45,698

 

 

See notes accompanying these condensed consolidated financial statements.

 

3



 

AVOCENT CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except per share data)

 

 

 

March 28,
2003

 

December 31,
2002

 

 

 

(unaudited)

 

(audited)

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

75,092

 

$

61,699

 

Investments maturing within one year

 

98,433

 

107,619

 

Accounts receivable, net

 

38,840

 

36,313

 

Income taxes receivable

 

356

 

609

 

Other receivables, net

 

1,028

 

1,191

 

Inventories, net

 

21,264

 

24,422

 

Other current assets

 

3,426

 

3,256

 

Deferred tax assets

 

5,257

 

5,932

 

Total current assets

 

243,696

 

241,041

 

Investments

 

65,316

 

44,849

 

Property held for lease, net

 

1,673

 

1,723

 

Property and equipment, net

 

23,759

 

24,313

 

Goodwill

 

203,625

 

203,625

 

Other intangible assets, net

 

46,485

 

52,601

 

Other assets

 

459

 

455

 

Total assets

 

$

585,013

 

$

568,607

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

5,779

 

$

6,416

 

Accrued wages and commissions

 

5,515

 

7,743

 

Accrued liabilities

 

12,511

 

13,662

 

Income taxes payable

 

10,481

 

6,901

 

Total current liabilities

 

34,286

 

34,722

 

Deferred tax liabilities

 

14,061

 

16,213

 

Total liabilities

 

48,347

 

50,935

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, $0.001 par value; 5,000 shares  authorized, no shares issued and outstanding as of March 28, 2003 and December 31, 2002, respectively

 

 

 

Common stock, $0.001 par value; 200,000 shares authorized, 45,687 and 45,210 shares issued and outstanding as of March 28, 2003 and  December 31, 2002, respectively

 

46

 

45

 

Additional paid-in capital

 

945,240

 

936,288

 

Accumulated other comprehensive income

 

273

 

14

 

Deferred compensation

 

(4,621

)

(6,236

)

Accumulated deficit

 

(404,272

)

(412,439

)

Total stockholders’ equity

 

536,666

 

517,672

 

Total liabilities and stockholders’ equity

 

$

585,013

 

$

568,607

 

 

See notes accompanying these condensed consolidated financial statements.

 

4



 

AVOCENT CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

 

 

 

For the three months ended

 

 

 

March 28,
2003

 

March 29,
2002

 

 

 

(unaudited)

 

(unaudited)

 

Cash flows from operating activities:

 

 

 

 

 

Net Income:

 

$

8,167

 

$

303

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

Depreciation

 

1,356

 

1,078

 

Amortization of intangible assets

 

6,156

 

5,297

 

Stock-based compensation

 

1,615

 

5,493

 

Amortization of premiums on investments

 

762

 

373

 

Net loss on sales of investments

 

87

 

75

 

Income tax benefit from exercise of stock options

 

1,687

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable, net

 

(2,527

)

8,353

 

Other receivables, net

 

163

 

1,061

 

Inventories, net

 

3,158

 

4,489

 

Other assets

 

(164

)

781

 

Accounts payable

 

(637

)

(1,102

)

Accrued wages and commissions

 

(2,228

)

230

 

Accrued liabilities

 

(1,151

)

(4,111

)

Income taxes, current and deferred

 

2,226

 

(1,275

)

Net cash provided by operating activities

 

18,670

 

21,045

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

Purchases of property and equipment

 

(802

)

(1,596

)

Purchases of investments

 

(45,111

)

(58,416

)

Maturities of investments

 

33,352

 

11,321

 

Proceeds from sales of investments

 

 

305

 

Net cash used in investing activities

 

(12,561

)

(48,386

)

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

Proceeds from issuance of common stock

 

7,266

 

1,794

 

Net cash provided by financing activities

 

7,266

 

1,794

 

 

 

 

 

 

 

Effect of exchange rate changes on cash and cash equivalents

 

18

 

(4

)

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalents

 

13,393

 

(25,551

)

Cash and cash equivalents at beginning of period

 

61,699

 

80,506

 

Cash and cash equivalents at end of period

 

$

75,092

 

$

54,955

 

 

See notes accompanying these condensed consolidated financial statements.

 

5



 

AVOCENT CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited, in thousands)

 

Note 1.   Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with generally accepted accounting principles and reflect all adjustments consisting of normal recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the results for the periods shown.  The results of operations for these periods are not necessarily indicative of the results expected for the full fiscal year or for any future periods.  The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates and assumptions.  Certain reclassifications have been made to the prior year financial statements to conform to the current year presentation.

 

The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the related notes contained in our Annual Report on Form 10-K for the year ended December 31, 2002, which is on file with the Securities and Exchange Commission.

 

We report our annual results based on years ending December 31.  We report our quarterly results for the first three interim periods based on 13 week periods ending on Fridays and for the fourth interim period ending on December 31.

 

Our financial statements are consolidated and include the accounts of Avocent Corporation and our wholly owned subsidiaries.  Significant inter-company transactions and balances have been eliminated in consolidation.

 

Note 2.   Inventories

 

Inventories consisted of the following at:

 

 

 

March 28,
2003

 

December 31,
2002

 

 

 

(unaudited)

 

(audited)

 

Raw materials

 

$

6,307

 

$

7,560

 

Work-in-process

 

1,061

 

851

 

Finished goods

 

13,896

 

16,011

 

Inventories, net

 

$

21,264

 

$

24,422

 

 

Inventories above have been reduced by reserves for excess and obsolete inventories of $8,076 and $7,502, as of March 28, 2003 and December 31, 2002, respectively.

 

Note 3.   Stock Options and Deferred Compensation

 

Deferred compensation — We recorded $41,165 of deferred compensation related to Cybex employee stock options at the time of the merger of Apex and Cybex on July 1, 2000.  Additionally, we recorded $2,752 of deferred compensation related to the Equinox employee stock options at the time of the acquisition on January 3, 2001.  The deferred compensation is being amortized over the vesting period of the options for which it was recorded.

 

Stock option exercises — Options to purchase 425 shares of our Common Stock were exercised during the quarter ended March 28, 2003.  We received proceeds totaling $6,609 from these option exercises. Additionally, 51 shares of our Common Stock were issued during the three months ending March 28, 2003 under our Employee Stock Purchase Plan.  We received proceeds totaling $657 from issuance these share issuances.

 

Note 4.   Accumulated Other Comprehensive Income

 

We record unrealized gains and losses on our foreign currency translation adjustments and unrealized holding gains or losses on our available-for-sale securities as accumulated other comprehensive income (loss), which is included as a separate component of stockholders’ equity.  For the three months ended March 28, 2003 and March 29, 2002, total other

 

6



 

comprehensive income amounted to $259 and $125, respectively.  As of March 28, 2003 and March 29, 2002, total accumulated other comprehensive income was $ 273 and $14, respectively.

 

Note 5.   Earnings Per Share

 

 

 

Income (loss)
(Numerator)

 

Shares
(Denominator)

 

Per-Share
Amount

 

 

 

 

 

 

 

 

 

For the three months ended March 28, 2003

 

 

 

 

 

 

 

Basic EPS

 

 

 

 

 

 

 

Net income available to common stockholders

 

$

8,167

 

45,413

 

$

0.18

 

Effect of Dilutive Securities

 

 

 

 

 

 

 

Stock options

 

 

1,278

 

 

Diluted EPS

 

 

 

 

 

 

 

Net income available to common stockholders and assumed conversions

 

$

8,167

 

46,691

 

$

0.17

 

 

 

 

 

 

 

 

 

For the three months ended March 29, 2002

 

 

 

 

 

 

 

Basic EPS

 

 

 

 

 

 

 

Net income available to common stockholders

 

$

303

 

44,828

 

$

0.01

 

Effect of Dilutive Securities

 

 

 

 

 

 

 

Stock options

 

 

870

 

 

Diluted EPS

 

 

 

 

 

 

 

Net income available to common stockholders and assumed conversions

 

$

303

 

45,698

 

$

0.01

 

 

Note 6.   Sales by Geographic Region

 

We report operations as a single operating segment; however, we report sales by geographic region.  Following is a presentation of sales by geographic region for the periods ended March 28, 2003 and March 29, 2002:

 

 

 

For the three months ended

 

 

 

March 28,
2003

 

March 29,
2002

 

 

 

(unaudited)

 

(unaudited)

 

Net sales:

 

 

 

 

 

United States

 

$

42,321

 

$

37,346

 

Rest of the World

 

28,841

 

24,757

 

 

 

$

71,162

 

$

62,103

 

 

As of March 28, 2003, long-lived assets totaled $275,542, which includes $273,899 held in the U.S. and $1,643 held outside of the U.S.  As of December 31, 2002, long-lived assets totaled $282,262, which includes $280,423 held in the U.S. and $2,305 held outside of the U.S.

 

Note 7.   Forward Contracts

 

We use forward contracts to reduce our foreign currency exposure related to the net cash flows from our international operations. The majority of these contracts are short-term contracts (three months or less) and are marked-to-market each quarter and included in trade payables, with the offsetting gain or loss included in other revenues in the accompanying statements of operations. At March 28, 2003, we had a liability related to two open forward contracts, both maturing in the second quarter of 2003, with a fair value at March 28, 2003 of approximately $157.

 

7



 

Note 8.   Goodwill and Other Intangible Assets

 

Acquired other intangible assets subject to amortization were as follows:

 

 

 

March 28, 2003

 

December 31, 2002

 

 

 

Gross
Carrying
Amounts

 

Accumulated
Amortization

 

Gross
Carrying
Amounts

 

Accumulated
Amortization

 

Developed technology

 

$

65,740

 

$

36,105

 

$

65,740

 

$

32,869

 

Patents and trademarks

 

17,482

 

6,635

 

17,350

 

5,663

 

Customer base and certification

 

21,113

 

17,772

 

21,113

 

16,013

 

Non-compete agreements

 

3,273

 

636

 

3,273

 

364

 

Other

 

101

 

76

 

101

 

67

 

 

 

$

107,709

 

$

61,224

 

$

107,577

 

$

54,976

 

 

For the three months ended March 28, 2003 and March 29, 2002, amortization expense for other intangible assets was $6.2 million and $5.3 million, respectively.  The approximate estimated annual amortization for other intangibles is as follows:

 

Years ending December 31:

 

 

 

2003

 

$

21,200

 

2004

 

$

17,300

 

2005

 

$

10,500

 

2006

 

$

2,100

 

2007

 

$

1,500

 

 

In accordance with Statement of Financial Accounting Standards No. 142, Goodwill and Other Intangible Assets, we will test goodwill at least annually for impairment.  Unless conditions warrant earlier review, we perform the annual impairment test in the fourth quarter of each year.

 

There were no additions or deletions to the carrying amount of goodwill for the three months ended March 28, 2003.

 

Note 9.   Shannon Building Purchase

 

In May 2003, Avocent Corporation’s wholly-owned subsidiary, Avocent International Ltd, signed a contract to purchase a 129,000 square foot facility in Shannon, Ireland, for 5,350 euros plus stamp duty (approximately $6,400 in total) from Tellabs Limited. The new facility and the currently leased space are both located in the Shannon Free Trade Zone.  In February 2003, we gave notice of our intent to terminate our current lease upon transfer of our European headquarters and manufacturing operations to the new facility, which is expected to occur in the summer of 2003. We paid a lease termination penalty of  $514 upon notification to the landlord of our intention to cancel the lease. This payment was expensed in the first quarter of 2003.  We expect to occupy the new purchased facility in the third quarter of this year.

 

Note 10.  Patent Dispute

 

In May 2001, Avocent Redmond Corp. (formerly Apex Inc.), our wholly-owned subsidiary, filed a complaint for patent infringement in the United States District Court for the Southern District of New York against Raritan Computer Inc. The Raritan complaint sought injunctive relief, damages, attorneys’ fees and costs under three Apex patents.  After a seven day bench trial in New York in January 2002, U.S. District Judge Milton Pollack found that there was no infringement of three patents by Raritan and ordered that judgment be entered in favor of Raritan.

 

In April 2003, the United States Court of Appeals for the Federal Circuit issued its ruling in the patent litigation between Avocent Redmond Corp. and Raritan Computer Inc.  The Court of Appeals ruled in favor of Avocent Redmond Corp. by vacating the non-infringement decision of the District Court for the Southern District of New York and remanding the case for further proceedings consistent with the Court of Appeals’ opinion.

 

8



 

Note 11.  Stock Based Compensation

 

We apply Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees, and related Interpretations in accounting for our stock plans. Had compensation cost for our stock-based compensation plans been determined based on the fair value at the grant dates for awards under those plans consistent with the method prescribed in SFAS No. 123, Accounting for Stock-Based Compensation, our  net income and earnings per share would have been reduced to the pro forma amounts indicated below:

 

 

 

2003

 

2002

 

Net income  — as reported

 

$

8,167

 

$

303

 

Add: Stock-based employee compensation expense included in reported net income (loss), net of related tax effects

 

1,501

 

4,583

 

Deduct: Total stock based employee compensation expense determined under fair value method for all awards, net of related tax effects

 

7,524

 

10,553

 

Net income (loss) — pro forma

 

$

2,144

 

$

(5,667

)

 

 

 

 

 

 

Basic earnings per share — as reported

 

$

0.18

 

$

0.01

 

Basic loss per share — pro forma

 

$

0.05

 

$

(0.13

)

Diluted earnings per share — as reported

 

$

0.17

 

$

0.01

 

Diluted loss per share — pro forma

 

$

0.05

 

$

(0.13

)

 

The pro forma amounts reflected above are not representative of the effects on reported net income in future years because, in general, the options granted typically do not vest for several years and additional awards are made each year. The fair value of each option grant is estimated on the grant date using the Black-Scholes option-pricing model using the following weighted-average assumptions:

 

 

 

2003

 

2002

 

Dividend yield

 

0.0

%

0.0

%

Expected life (years)

 

5

 

5

 

Expected volatility

 

67.5

%

67.5

%

Risk-free interest rate

 

2.55

%

4.47

%

 

Note 12.  Recently Issued Accounting Standards

 

In July 2002, the Financial Accounting Standards Board issued SFAS No. 146, Accounting for Costs Associated with Exit or Disposal, which is effective for disposal or exit activities that are initiated after December 31, 2002. We adopted this statement effective January 1, 2003.  This statement addresses financial accounting and reporting for costs associated with exit or disposal activities and nullifies Emerging Issues Task Force Issue No. 94-3, Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (Including Certain Costs Incurred in a Restructuring).  The statement requires that a liability for a cost associated with an exit or disposal activity shall be recognized and measured initially at its fair value in the period in which liability is incurred, except for liabilities for one-time termination benefits that are accrued over time.  In the unusual circumstance in which fair value cannot be reasonably estimated, the liability shall be recognized initially in the period in which fair value can be reasonably estimated.  The impact of SFAS No. 146 was not material to our financial statements.

 

9



 

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

THE INFORMATION IN THIS ITEM 2 “MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS” CONTAINS FORWARD-LOOKING STATEMENTS, INCLUDING, WITHOUT LIMITATION, STATEMENTS RELATING TO OUR FUTURE BUSINESS PROSPECTS AND ECONOMIC CONDITIONS IN GENERAL, STATEMENTS REGARDING OUR ENGINEERING AND DESIGN ACTIVITIES, PRODUCT DEVELOPMENT, AND NEW PRODUCT INTRODUCTIONS, STATEMENTS RELATING TO FUTURE PRODUCT DEMAND AND OUR FUTURE SALES, EARNINGS, GROSS PROFIT, INCOME, AND EXPENSES, STATEMENTS REGARDING INTERNATIONAL SALES, STATEMENTS REGARDING MERGER ACCOUNTING, ACQUISITION, AND TRANSACTION COSTS AND ADJUSTMENTS, STATEMENTS ABOUT THE RATIO OF SALES AMONG OUR DISTRIBUTION CHANNELS, STATEMENTS REGARDING FUTURE INVENTORY LEVELS, STATEMENTS ABOUT THE TIMING, IMPLEMENTATION, AND BENEFITS OF OUR NEW ERP SYSTEM AND THE PURCHASE OF OUR NEW FACILITY IN SHANNON, IRELAND, AND STATEMENTS RELATING TO ANTICIPATED CAPITAL NEEDS AND USES.

 

THESE FORWARD-LOOKING STATEMENTS ARE SUBJECT TO CERTAIN RISKS AND UNCERTAINTIES THAT COULD CAUSE OUR ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE ANTICIPATED IN THE FORWARD-LOOKING STATEMENTS.  FACTORS THAT MIGHT CAUSE SUCH A DIFFERENCE INCLUDE, BUT ARE NOT LIMITED TO, THE RISKS ASSOCIATED WITH GENERAL ECONOMIC CONDITIONS, RISKS ATTRIBUTABLE TO FUTURE PRODUCT DEMAND, SALES, AND EXPENSES, RISKS ASSOCIATED WITH PRODUCT DESIGN EFFORTS, RISKS ASSOCIATED WITH RELIANCE ON A LIMITED NUMBER OF COMPONENT SUPPLIERS AND SINGLE SOURCE COMPONENTS, THE LOSS OF ONE OF OUR OEM CUSTOMERS, A REDUCTION OR FLUCTUATIONS IN SALES OF OUR OEM OR BRANDED PRODUCTS, INTENSE COMPETITION AND NEW PRODUCTS AND TECHNOLOGIES FROM EXISTING AND NEW COMPETITORS, RISKS RELATED TO PROTECTING OUR INTELLECTUAL PROPERTY RIGHTS, FLUCTUATIONS IN FOREIGN CURRENCIES, RISKS RELATED TO MERGER INTEGRATION, AND OTHER RISKS DETAILED IN OUR  ANNUAL REPORT ON FORM 10-K, WHICH WAS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON MARCH 27, 2003.

 

Overview

 

We design, manufacture, and sell analog and digital KVM (keyboard, video and mouse) switching systems, serial connectivity devices, extension and remote access products, technologies, software, and display products for the computer industry. Data center managers and network administrators have increasingly complex and growing server populations, and our analog, digital, and serial switching solutions, as well as our extension and remote access products, technologies, and software, help them manage multiple servers and serially controlled devices from a single local or remote console consisting of a keyboard, video monitor, and mouse.  Specifically, our products can provide significant cost reductions including lower initial investment, reduced utility costs, and space savings, as well as more efficient technical support capabilities.

 

We provide “plug and play” switching systems for many network administration, management, and storage problems faced by corporate customers, data centers, and server farms. Our switching solutions include products, technologies and software sold or licensed under the Avocent, Apex, Cybex, Equinox, and 2C brands, including our AMX™ , AutoView™, DS Series™, OutLook®, and XP®4000 Series products. Our switching systems and solutions help facilities managers and network administrators access multiple servers and serially controlled devices from one or more centralized or remote consoles, consolidate hardware requirements, and provide direct hardwired connections between the switch and the attached servers to facilitate access to those servers, even when the network is down. Our Equinox branded products add high-performance, reliable, and affordable server-based products for serial and dial-up access applications.  The Equinox SuperSerial product line provides serial communications for security, commercial point-of-sale, process control, industrial automation, data collection, remote access, fax servers, Internet access, and custom applications. Our 2C product line includes the Cstation product.  Initial applications for Cstation include financial trading floors where space is at a premium, industrial plant control environments that benefit from remote computers due to harsh or unsecured environments, and government installations that require high security afforded through the remote location of the computer and hard disk.

 

A substantial portion of our revenue is derived from sales to a limited number of OEMs who purchase our switching systems on a private-label or branded basis for integration and sale with their own products, sales through our reseller and distributor network, and sales to a limited number of direct customers. For the quarter ended March 28, 2003, sales to our OEM customers were 47% of net sales, sales to our reseller and distributor network were 51% of net sales, and sales to our direct customers were 2% of net sales. We do not have contracts with many of these customers, and in general, they are obligated to purchase products from us only pursuant to binding purchase orders.  The loss of, or material decline in orders from, our OEM customers would have a material adverse effect on our business, financial condition, results of operation, and cash flow.  Our top five customers, who include OEMs and distributors, accounted for 62.6% of our sales for the quarter ended March 28, 2003.

 

We sell our products in the United States, Canada, Europe and Asia as well as in other foreign markets.  Sales within the

 

10



 

United States accounted for approximately 59.5% of sales in the quarter ended March 28, 2003, while sales outside of the United States accounted for 40.5% of sales in the quarter ended March 28, 2003.

 

With recent industry-wide initiatives to reduce all channel inventories and to shorten lead times, trends with our major customers are, generally, to reduce the number of weeks of forward-committed firm orders. This trend is currently affecting our business with certain distributors, OEMs and other server manufacturers, and we believe that it will make our future sales more difficult to predict and inventory levels more difficult to manage.

 

We are currently experiencing increased price competition in the market for all of our products, and we expect that pricing pressures will continue to increase in the future.  In addition, general economic conditions are not as favorable as they were in prior years, and our revenue growth rate has slowed.  Depending on future general economic conditions and other factors, our revenue could decline in the future.

 

We received ISO 9000:2000 accreditation for our global business processes during the first quarter of 2003.  We believe ISO accreditation will become a requirement for doing business with several of our OEM customers.

 

Many of our executive officers and directors are vested in significant amounts of options to purchase shares of our common stock and continue to vest in additional shares on a regular basis.  These officers and directors have informed us that they have sold and may sell additional shares of our common stock to provide personal liquidity and diversify their portfolios.

 

During 2003 we commenced implementation of a new enterprise resource planning system which we expect to have fully operational in 2004. We have capitalized costs related to the ERP project of over $1.6 million through March 28, 2003.  We expect the total cost of implementing the system to be in the range of $11.0 million to $12.2 million.  We expect the new system will provide many benefits, including more detailed information to improve the ways we manage inventory, customer relationships and operating expenses on more a timely basis.  The implementation of the new system involves a number of risks, as detailed in our Risk Factors contained in our Form 10-K for December 31, 2002.

 

Results of Operations

 

The following table sets forth, for the periods indicated, selected statement of operations data expressed as a percentage of net sales:

 

 

 

Three Months Ended

 

 

 

March 28,
2003

 

March 29,
2002

 

Net sales

 

100.0

%

100.0

%

Cost of sales

 

44.4

 

51.3

 

Gross profit

 

55.6

 

48.7

 

Operating expenses:

 

 

 

 

 

Research and development expenses

 

9.6

 

10.4

 

Selling, general and administrative expenses

 

23.4

 

32.0

 

Amortization of intangible assets

 

8.6

 

8.5

 

Total operating expenses

 

41.6

 

50.9

 

 

 

 

 

 

 

Income (loss) from operations

 

14.0

 

(2.2

)

 

 

 

 

 

 

Net investment income

 

1.7

 

2.2

 

Net realized investment losses

 

(0.1

)

(0.1

)

Other income (expense), net

 

(0.4

)

0.1

 

 

 

 

 

 

 

Loss before provision for (benefit from) income taxes

 

15.2

 

(0.0

)

 

 

 

 

 

 

Provision for (benefit from) income taxes

 

3.7

 

(0.5

)

 

 

 

 

 

 

Net income

 

11.5

%

0.5

%

 

Net sales.  Net sales increased 15% to $71.2 million for the first quarter of 2003 from $62.1 million for the first quarter of 2002.  The increase in sales resulted primarily from the strength of our OEM and our reseller and distributor channels in the first quarter of 2003 as compared to the first quarter of 2002.  Both the reseller and distributor channel and the OEM channel benefited

 

11



 

from revenue from new products introduced during the second half of 2002. The new products include the AMX and the AVR and OEM versions of our digital product family.  These new products accounted for more than $12.5 million of first quarter 2003 sales.  Sequentially, our sales increased approximately $200,000 from the fourth quarter of 2002.  The sequential increase in sales was due to strength in our branded U.S. sales, which helped offset lower overall OEM sales.   Our OEM sales declined 6% from the fourth quarter of 2002.  This decline in OEM sales compares favorably to the 9% sequential decline from the fourth quarter of 2001 to the first quarter of 2002.  We attribute most of this improvement to the continued ramp up in sales of our digital products through the OEM channel.  The sequential decline from the fourth quarter of 2002 to the first quarter of 2003 in OEM sales was offset by an improvement in our reseller and distributor business, which increased approximately 9% from the fourth quarter of 2002. Sales through our reseller and distributor channel increased 10% from $32.8 million in the first quarter of 2002 to $36.1 million in the first quarter of 2003. Direct sales increased 29% from $1.5 million in the first quarter of 2002 to $1.8 million in the first quarter of 2003. OEM sales increased 19% from $27.8 million in the first quarter of 2002 to $33.2 million in the first quarter of 2003. Reseller and distributor sales were 51% of sales for the first quarter of 2003, compared to 53% of sales for the first quarter of 2002.  OEM sales were 47% of sales for the first quarter of 2003, compared to 45% of sales for the first quarter of 2002.  Direct sales were 2% of sales for the first quarter of 2003 and 2002.

 

We experienced an increase in sales both within the United States and internationally. Sales within the United States increased 13% to 42.3 million in the first quarter of 2003 from $37.3 million in the first quarter of 2002.  International sales increased 16% to $28.9 million in the first quarter of 2003 from $24.8 million in the first quarter of 2002.  Sales within the United States were 60% of sales for the first quarter of both 2003 and 2002, and international sales were 40% of sales for the first quarter of both 2003 and 2002.

 

Gross profit. Gross profit may be affected by a variety of factors, including: the ratio of sales among our distribution channels, as OEM sales typically have lower gross margins than our reseller and distributor sales and direct sales; absorption of fixed costs as sales levels fluctuate; product mix, raw materials, and labor costs; new product introductions by us and by our competitors; and the level of our outsourcing of manufacturing and assembly services.  Gross profit increased to 55.6% in the first quarter 2003 as compared to 48.7% in the first quarter of 2003.  The primary reasons for strong margins in 2003 were cost reductions and favorable customer and product mix.  Our costs declined in the first quarter of 2003 primarily due to improved pricing from our vendors and the cessation of the West Coast port labor dispute.  Our U.S. branded sales were up significantly from last year and these sales carry a higher gross margin than our OEM and international sales.  Our digital family of products has higher gross margins than our other products and accounted for 33% of total sales for the first quarter of 2003, compared to 19% of sales for the first quarter of 2002.  In future quarters we expect gross margin to return to the 52% to 54% range as OEM and international sales increase as a percentage of our sales mix.

 

Research and development expenses.  Research and development expenses include compensation for engineers, support personnel, outside contracted services and materials costs, and are expensed as they are incurred.  Research and development expenses were $6.8 million, or 9.6% of net sales, in the first quarter of 2003 compared to $6.4 million, or 10.4% of net sales, for the first quarter of 2002.  The increase in the amount spent on research and development can be attributed to an increase in headcount, primarily as a result of the 2C purchase in the third quarter of 2002, and an increase in materials, certification, and testing of products currently in development. We believe that the timely development of innovative products and enhancements to existing products is essential to maintaining our competitive position.  We expect research and development expenditures to be at the same level in the second quarter of 2003 as in the first quarter of 2003.

 

Selling, general and administrative expenses.  Selling, general and administrative expenses include personnel costs for administration, finance, information systems, human resources, sales and marketing and general management, as well as some merger and acquisition related expenses, rent, utilities, legal and accounting expenses, bad debts, advertising, promotional material, trade show expenses and related travel costs.  Selling, general and administrative expenses were $16.7 million, or 23.4% of net sales, for the first quarter of 2003 compared to $19.9 million, or 32.0% of net sales, for the first quarter of 2002.  The decrease in selling, general and administrative expenses was affected by our decision to expense $2.7 million in legal fees during the first quarter of 2002.  Approximately $1.8 million of these fees were deferred from previous periods and $900 thousand of fees were incurred during the first quarter of 2002. These fees related to the patent infringement lawsuit we brought against one of our competitors challenging the use of on-screen technology in the competitor’s switches.  A court decision was reached in February 2002 that found no infringement of the three patents involved in the lawsuit.  The judgment was vacated by the United States Court Appeals in April 2003 and remanded back to the district court.  We intend to continue to vigorously pursue the lawsuit.  Nevertheless, we continue to expense these legal fees due to the uncertainty of the litigation.  In addition, we recorded $2.0 million of compensation expense in the first quarter of 2002 as the result of a cashless option exercise.  We allowed shares issued upon the exercise of certain options by a former executive to be traded as payment for the cost of these options and the related taxes.  Under applicable accounting rules, this cashless exercise required variable plan accounting for these options.  The reduction in selling, general and administrative expenses was partially offset by a $514,000 lease cancellation fee we paid and expensed in the first quarter of 2003 related to the purchase of a new facility in Shannon, Ireland.  We expect selling, general and administrative expenditures to decline slightly in the second quarter of 2003 from the level we experienced in the first quarter of 2003.

 

12



 

Amortization of intangible assets.  Amortization of $6.2 million in 2003 is comprised of the amortization of the identifiable intangible assets created as a result of the merger transaction between Apex and Cybex and the acquisitions of Equinox and 2C, while amortization of $5.3 million in 2002 includes the amortization of the identifiable intangible assets created as a result of the merger transaction between Apex and Cybex and the acquisition of Equinox.  The increase in amortization expense relates primarily to the additional expense for intangible assets recorded at the acquisition of 2C.

 

Net investment income.  Net investment income decreased to $1.2 million in the first quarter of 2003 from $1.4 million in the first quarter of 2002.  Although we had more cash and investments in 2003 than in 2002, interest income has declined due to lower interest rates.

 

Net realized investment losses.  Net realized investment losses remained relatively flat from $75,000 in the first quarter of 2002 to $87,000 in first quarter of 2003.

 

Other income (expense), net.  Net other income (expense) decreased from income of $53,000 in the first quarter of 2002, to expense of $305,000 in the first quarter of 2003. The decline related primarily to foreign exchange losses of $294,000 recorded in the first quarter of 2003 as compared to gains of approximately $60,000 recorded in the first quarter of 2002. This decline relates primarily to the change in the exchange rate of the dollar versus the euro.

 

Provision for (benefit from) income taxes.  The provision for income taxes was approximately $2.6 million for the first quarter of 2003, compared to a benefit from income taxes of $333,000 in the first quarter of 2002.  The change in taxes resulted from the impact of merger related expenses on lower sales volume and taxable income in the first quarter of 2002 as compared to higher sales volume and higher taxable income in 2003. Also affecting our tax rate was the mix of our pre-tax profit among our U.S. and international companies.

 

Net income (loss).  Net income for the first quarter of 2003 was $8.2 million compared to $303,000 for the first quarter of 2002, as a result of the above factors, including the increase in our revenues and our margins, as well as a reduction in selling, general and administrative charges.  Net income as a percentage of sales for the first quarter of 2003 was 11.5%, compared to 0.5% for the first quarter of 2002.

 

Liquidity and Capital Resources

 

As of March 28, 2003, our principal sources of liquidity consisted of over $238 million in cash, cash equivalents, and investments.  We have no outstanding debt or available credit facilities as of this filing.

 

Our operating activities generated cash of over $18 million in the first three months of 2003, compared to approximately $21 million in the first three months of 2002.  The continued strong cash flow from operations in the first quarter of 2003 is primarily the result of increased net income and our continued focus on managing our receivables and inventory that has carried over from 2002.  Inventories declined from $24.4 million at December 31, 2002 to $21.3 million at March 28, 2003.  The decline in inventory was the result of the continued efforts of our operations group, at all of our locations, to increase turnover by consuming existing supplies while maintaining adequate inventory to meet customer demands.  Inventories were also affected by increases to our reserves and valuation accounts.  We anticipate that inventories will trend downward slightly during 2003.  Additionally, we recorded a tax benefit from the exercise of stock options of over $1.6 million in the first quarter of 2003.  We experienced significant exercises of stock options in the first quarter of 2003 as our stock achieved new 52-week highs in February and March of 2003.  An increase in receivables partially offset the impact of the decline in inventory and the tax benefit from options.  The increase in receivables was a result of the timing and volume of sales in the first quarter of 2003.  A decline in accrued compensation also affected cash flow from operations for the first quarter of 2003.  Overall, our annual employee bonuses were larger for 2002 than for 2001 and we paid these bonuses to our employees shortly after year-end in efforts to tie the reward to the improved results of 2002.

 

In February 2003 we agreed in principle, and in May 2003, we signed a definitive contract to purchase a facility in Shannon, Ireland for approximately 6.0 million euros to replace our currently leased space in Shannon.  We expect to occupy and transfer our operations to the new facility in the summer of 2003.  We purchased a currency forward to hedge the purchase price at approximately $6.4 million.  Additionally, in February 2003 we paid an early cancellation fee of approximately $514,000 to the owner of our current leased facility, which we recognized as an expense in the first quarter of 2003.

 

We intend to use a portion of our cash and investments for strategic acquisitions of technologies and companies that will enhance and complement our existing technologies and help increase our sales.

 

13



 

Investments

 

Our investments consist of corporate bonds, commercial paper, mortgage backed securities guaranteed by U.S. government agencies, and common stock. Debt securities that we have the positive intent and ability to hold to maturity are classified as held-to-maturity securities and are reported at amortized cost. Debt and equity securities not classified as held-to-maturity securities and that have readily determinable fair values are classified as available-for-sale securities and are reported at fair value, with unrealized gains and losses excluded from earnings and reported as a separate component of stockholders’ equity. We periodically review our investment portfolio for investments considered to have sustained an other-than-temporary decline in value.   Upon review of our investment portfolio as of March 28, 2003, no investment was considered to have sustained an other-than-temporary decline, and no charge was recorded.

 

Critical Accounting Policies

 

We believe the following critical accounting policies affect the more significant judgments and estimates used in the preparation of our consolidated financial statements:

 

              We review customer contracts to determine if all of the requirements for revenue recognition have been met prior to recording revenues from sales transactions.  We generally record sales revenue upon shipment of our products, net of any discounts, since we generally do not have significant post delivery obligations, the product price is fixed and determinable, collection of the resulting receivable is probable, and product returns are reasonably estimable.  We generally ship products upon receipt of a purchase order from a customer.  We record revenue in accordance with the applicable terms of each respective customer contract.  Accordingly, revenue on products shipped FOB destination is recorded when the customer takes possession of the goods, and revenue on products shipped FOB shipping point is recorded when the goods leave our facilities.  Shipping and handling fees are included in net sales, and the related costs are included in cost of sales in the accompanying consolidated statements of operations

 

We accrue for sales returns as a reduction of sales and cost of sales based on our experience from historical customer returns, which we believe provides a reasonable estimate of future returns.  Our sales agreements generally include a one-month unconditional return policy.  We also allow additional rights of return to certain distributors, which generally extend the return period to 90 days.  If actual future customer returns are less favorable than those projected by management, additional sales return costs may be incurred.  The reserve is included as a reduction in the carrying value of accounts receivable in the accompanying consolidated balance sheets.

 

Prior to extending credit to a new customer, we perform a detailed credit review of the customer and establish credit limits based on the results of our credit review.  We review collection experience periodically to determine if the customer’s payment terms and credit limits need to be revised.  We maintain allowances for doubtful accounts for estimated losses resulting from the inability of our customers to make required payments.  If the financial condition of our customers were to deteriorate, resulting in an impairment of their ability to make payments, additional allowances may be required.  If circumstances change with regard to individual receivable balances that had previously been determined to be uncollectible (and for which a specific reserve had been established), a reduction in our allowance for doubtful accounts may be required.

 

              We carry our inventory at the lower of cost or market, with cost being determined using the first-in, first-out method.  We use standard costs for material, labor, and manufacturing overhead to value our inventory.  We review and revise our standard costs on a quarterly basis.  Therefore, our inventory costs approximate actual costs at the end of each reporting period.  We write down our inventory for estimated obsolescence or unmarketable inventory to the estimated market value based upon assumptions about future demand and market conditions.  If actual future demand or market conditions are less favorable than those projected by management, additional inventory write-downs may be required.

 

              We provide for the estimated cost of product warranties at the time revenue is recognized.  While we engage in extensive product quality programs and processes, including actively monitoring and evaluating the quality of our component suppliers and contract manufacturers, our warranty obligation is affected by product failure rates, failure rates of purchased components integrated into our products, material usage, and other rework costs incurred in correcting a product failure.  Should actual product failure rates, material usage, or other rework costs differ from our estimates, revisions to our estimated warranty liability may be required.

 

              We hold investments in various publicly traded equity and debt securities, including mortgaged-backed and other asset-backed securities.  We record an investment impairment charge when we believe an investment has

 

14



 

experienced a decline in value that is other than temporary.  Future adverse changes in market conditions or poor operating results of underlying investments could result in losses or an inability to recover the carrying value of the investments that may not be reflected in an investment’s current carrying value, thereby possibly requiring an impairment charge in the future.

 

                We also invest in privately held entities and generally record our investments in these entities at cost or we use the equity method if we have the ability to exercise significant influence over the entity.  We review our investments in these entities periodically to determine if circumstances (both financial and non-financial) exist that indicate that we will not recover our initial investment.  We record impairment charges on investments having a carrying value that is greater than the value that we would reasonably expect to receive in an arm’s length sale of the investment.

 

              During the first quarter of 2003 we began implementing a new ERP system.  In accordance with SOP 98-1, "Accounting for the Costs of Computer Software Developed or Obtained for Internal Use," we will capitalize the direct costs incurred during the application development stage of the implementation.  The costs capitalized to date for the new system totaled $1.6 million as of March 28, 2003.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risks.

 

Our primary market risk is the potential loss arising from increases in interest rates, which could have an adverse impact on the fair value of our investment securities. Our investment policy is to manage our investment portfolio to preserve principal and liquidity while maximizing the return on our investment portfolio through the investment of available funds. We diversify our investment portfolio by investing in a variety of highly-rated investment-grade securities and through the use of different investment managers. Our investment securities portfolio is primarily invested in securities with maturities (or interest rate resets) of two years or less with at least an investment grade rating to minimize interest rate and credit risk as well as to provide for an immediate source of funds. Market risk, calculated as the potential change in fair value in our investment portfolio resulting from a hypothetical 10% change in interest rates, was not material at March 28, 2003. We generally hold investment securities until maturity.

 

We are also exposed to equity price risks on our investments in publicly traded equity securities. These investments are generally in companies having operations or technology in areas within our strategic focus. We do not attempt to reduce or eliminate our market exposure on these securities. As of March 28, 2003, the fair value of our equity investments was $996,000. A 20% adverse change in equity prices would result in a decrease of approximately $199,000 in the fair value of our equity securities as of March 28, 2003.

 

We also face foreign currency exchange rate risk to the extent that the value of certain foreign currencies relative to the U.S. dollar affects our financial results.  Our international operations transact a portion of our business in currencies other than the U.S. dollar, predominantly the euro, and changes in exchange rates may positively or negatively affect our revenues, gross margins, operating expenses, and retained earnings since these transactions are reported by us in U.S. dollars.  We occasionally purchase foreign currency forwards aimed at limiting the impact of foreign currency fluctuations.  These instruments provide only limited protection against currency exchange risks, and there can be no assurance that such an approach will be successful, especially if a significant and sudden decline occurs in the value of local currencies. At March 28, 2003, we had two open forward contracts, both maturing in the second quarter of 2003, with a fair value at March 28, 2003 of approximately $157,000.

 

Item 4. Controls and Procedures.

 

(a) Evaluation of disclosure controls and procedures.    Based on their evaluation as of a date within 90 days of the filing date of this Quarterly Report on Form 10-Q, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-14(c) and 15d-14(c) under the Securities Exchange Act of 1934) are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.

 

(b) Changes in internal controls.    There were no significant changes in our internal controls or in other factors that could significantly affect these controls subsequent to the date of their evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

 

15



 

PART II — OTHER INFORMATION

 

Item 1.    Legal Proceedings.

 

In May 2001, Avocent Redmond Corp. (formerly Apex Inc.), our wholly-owned subsidiary, filed a complaint for patent infringement in the United States District Court for the Southern District of New York against Raritan Computer Inc. The Raritan complaint sought injunctive relief, damages, attorneys’ fees and costs under three Apex patents.  After a seven day bench trial in New York in January of 2002, U.S. District Judge Milton Pollack found that there was no infringement of three patents by Raritan and ordered that judgment be entered in favor of Raritan.

 

In April 2003, the United States Court of Appeals for the Federal Circuit issued its ruling in the patent litigation between Avocent Redmond Corp. and Raritan Computer Inc.  The Court of Appeals ruled in favor of Avocent Redmond Corp. by vacating the non-infringement decision of the District Court for the Southern District of New York and remanding the case for further proceedings consistent with the Court of Appeals’ opinion.

 

Item 6.    Exhibits and Reports on Form 8-K.

 

(a) Exhibits

 

 

10.38

 

Purchase contract for facility in Shannon, Ireland, by and among Avocent International Limited and Tellabs Limited.

 

 

 

 

 

99.4

 

Certification of Chief Executive Officer and Chief Financial Officer

 

(b) Reports on Form 8-K

 

On January 30, 2003, we filed a Report on Form 8-K with the SEC regarding the public dissemination of a press release announcing the financial results for our fourth quarter and year ended December 31, 2002.

 

ITEMS 2, 3, 4, AND 5 ARE NOT APPLICABLE AND HAVE BEEN OMITTED.

 

16



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

 

AVOCENT CORPORATION.

 

 

 

(Registrant)

 

 

 

 

 

 

Date:

May 9, 2003

/s/ Douglas E. Pritchett

 

 

 

Douglas E. Pritchett

 

 

Senior Vice President of Finance, Chief Financial

 

 

Officer and Treasurer (Principal Financial Officer)

 

17



 

Sarbanes-Oxley Act of 2002 Section 302(a) Certification of Chief Executive Officer

 

I, John R. Cooper, certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q of Avocent Corporation;

 

 

 

2.

Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

 

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

 

 

 

4.

The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

 

 

 

 

a)

designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

 

 

 

 

b)

evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and

 

 

 

 

c)

presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

 

 

 

5.

The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

 

 

 

a)

all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

 

 

 

 

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

 

 

 

6.

The registrant’s other certifying officers and I have indicated in this quarterly report whether there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

 

Date: May 9, 2003

 

 

 

 

 

 

/s/ John R. Cooper

 

 

John R. Cooper

 

President and Chief Executive Officer

 

18



 

Sarbanes-Oxley Act of 2002 Section 302(a) Certification of Chief Financial Officer

 

I, Douglas E. Pritchett, certify that:

 

1.

I have reviewed this quarterly report on Form 10-Q of Avocent Corporation;

 

 

 

2.

Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

 

 

 

3.

Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

 

 

 

4.

The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

 

 

 

 

a)

designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

 

 

 

 

b)

evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and

 

 

 

 

c)

presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

 

 

 

5.

The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

 

 

 

 

a)

all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

 

 

 

 

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

 

 

 

6.

The registrant’s other certifying officers and I have indicated in this quarterly report whether there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

 

Date: May 9, 2003

 

 

 

 

/s/ Douglas E. Pritchett

 

 

Douglas E. Pritchett

 

Senior Vice President of Finance, Chief Financial Officer, Treasurer and Assistant Secretary

 

19